News + Filings Transactions
|
JANNEY DANIEL
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/30/2023 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $117.40 | $798.3k | | 06/30/2023 |
06/09/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 10k | $128.53 | $1.3M | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/09/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 5k | $128.84 | $644.2k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/09/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 3.9k | $129.29 | $508.8k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 5k | $127.86 | $639.3k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 10k | $127.96 | $1.3M | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 5k | $127.96 | $639.8k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 5.4k | $128.73 | $693.6k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 1.1k | $129.02 | $138.4k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
06/08/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 4.6k | $127.96 | $589.1k | Directly beneficially owned by Alta Bioequities, L.P. | 06/08/2023 |
05/25/2023 | Allakos Inc. | ALLK | Grant | Stock Option (Right to buy) | 86.8k | $4.81 | $417.3k | | 05/25/2023 |
05/19/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 50k | $95.02 | $4.8M | Directly beneficially owned by Alta Bioequities, L.P. | 05/19/2023 |
05/09/2023 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 17.1k | $90.74 | $1.6M | Directly beneficially owned by Alta Bioequities, L.P. | 05/09/2023 |
09/21/2022 | Allakos Inc. | ALLK | Purchase | Common Stock | 475k | $5.02 | $2.4M | By Alta Partners NextGen Fund I, L.P. | 09/21/2022 |
06/30/2022 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $65.66 | $446.5k | | 06/30/2022 |
05/25/2022 | Allakos Inc. | ALLK | Grant | Stock Option (Right to buy) | 99.6k | $2.62 | $260.9k | | 05/25/2022 |
12/10/2021 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 100k | $70.50 | $7M | By Alta Bioequities L.P | 12/10/2021 |
06/30/2021 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $68.00 | $462.4k | | 06/30/2021 |
05/27/2021 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 12.4k | $0.00 | $0 | | 05/27/2021 |
05/25/2021 | Allakos Inc. | ALLK | Grant | Stock Option (Right to buy) | 7.7k | $99.83 | $768.7k | | 05/25/2021 |
03/26/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 14.8k | $115.01 | $1.7M | By Alta Bioequities L.P. | 03/26/2021 |
03/26/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 2.5k | $116.09 | $290.2k | By Alta Bioequities L.P. | 03/26/2021 |
03/22/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 9k | $119.46 | $1.1M | By Alta Bioequities L.P. | 03/22/2021 |
03/22/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 4.1k | $120.22 | $495.1k | By Alta Bioequities L.P. | 03/22/2021 |
03/15/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 6.7k | $124.56 | $835.5k | By Alta Bioequities L.P. | 03/12/2021 |
03/12/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 4.1k | $124.18 | $505.5k | By Alta Bioequities L.P. | 03/12/2021 |
03/11/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 6k | $124.62 | $748.5k | By Alta Bioequities L.P. | 03/09/2021 |
03/09/2021 | Allakos Inc. | ALLK | Sale | Common Stock | 100 | $125.00 | $12.5k | By Alta Bioequities L.P. | 03/09/2021 |
06/30/2020 | Krystal Biotech, Inc. | KRYS | Grant | Stock Option (Right to Buy) | 6.8k | $41.42 | $281.7k | | 06/30/2020 |
05/28/2020 | Esperion Therapeutics, Inc. | ESPR | Grant | Common Stock | 6.1k | $0.00 | $0 | | 05/28/2020 |
05/26/2020 | Allakos Inc. | ALLK | Grant | Stock Option (Right to Buy) | 7.7k | $72.54 | $558.6k | | 05/26/2020 |
08/30/2019 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 32.2k | $46.18 | $1.5M | See footnotes | 08/29/2019 |
08/29/2019 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 55.8k | $46.61 | $2.6M | See footnotes | 08/29/2019 |
08/29/2019 | Krystal Biotech, Inc. | KRYS | Sale | Common Stock | 700 | $47.50 | $33.2k | See footnotes | 08/29/2019 |
06/17/2019 | SUTRO BIOPHARMA, INC. | STRO | Grant | Stock Option (right to buy Common Stock) | 11.6k | $11.12 | $129.1k | | 06/17/2019 |
|
|